{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:53:58Z","timestamp":1785898438562,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1989,3]]},"DOI":"10.1007\/bf01536042","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T07:18:34Z","timestamp":1113895114000},"page":"S14-S27","source":"Crossref","is-referenced-by-count":83,"title":["Use of somatostatin analog in management of carcinoid syndrome"],"prefix":"10.1007","volume":"34","author":[{"given":"Aaron","family":"Vinik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Moattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"637","volume":"137","author":"Z Davis","year":"1973","unstructured":"Davis Z, Moertel CG, Mclirath DC: The malignant carcinoid syndrome. Surg Gynec Obstet 137:637?644, 1973","journal-title":"Surg Gynec Obstet"},{"issue":"Suppl 6b","key":"CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(86)90581-4","volume":"81","author":"KD Buchanan","year":"1986","unstructured":"Buchanan KD, Johnston CF, O'Hare MMT, et al: Neuroendocrine tumors. A European view. Am J Med 81 (Suppl 6b): 14?22, 1986","journal-title":"Am J Med"},{"key":"CR3","first-page":"1","volume-title":"Gastrointestinal Hormones","author":"E Solcia","year":"1988","unstructured":"Solcia E, Capella C, Buffa R, Frigerio B, Usellini L, Fiocca R: Morphological and functional classification of endocrine cells and related growths in the gastrointestinal tract.In Gastrointestinal Hormones. GBJ Glass (ed). New York, Raven Press, 1988, pp 1?17."},{"key":"CR4","first-page":"433","volume":"63","author":"C Weil","year":"1985","unstructured":"Weil C: Gastroenteropancreatic endocrine tumors. Klivo 63:433?459, 1985","journal-title":"Klivo"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/1097-0142(19841001)54:7<1364::AID-CNCR2820540722>3.0.CO;2-Y","volume":"54","author":"S Simpson","year":"1984","unstructured":"Simpson S, Vinik AI, Marangos PJ, Lloyd RV: Immunohistochemical localization of neuron-specific enolase in gastroentero-pancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase. Cancer 54:1364, 1984","journal-title":"Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","volume":"1","author":"CG Moertel","year":"1983","unstructured":"Moertel CG: Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1:727?740, 1983","journal-title":"J Clin Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4","volume":"36","author":"JD Godwin II","year":"1975","unstructured":"Godwin JD II: Carcinoid tumors an analysis of 2837 cases. Cancer 36:560?569, 1975","journal-title":"Cancer"},{"key":"CR8","first-page":"293","volume-title":"Endocrine Surgery Update","author":"W Strodel","year":"1983","unstructured":"Strodel W, Vinik A, Thompson N, et al: Carcinoid tumors of the small intestine.In Endocrine Surgery Update. NW Thompson, AI Vinik (eds). New York, Grune & Stratton, 1983, pp 293?320"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0016-5085(65)80089-0","volume":"48","author":"KL Melmon","year":"1965","unstructured":"Melmon KL, Sjoerdsma A, Oates JA, Laster L: Treatment of malabsorption and diarrhea of carcinoid syndrome with methysergide. Gastroenterology 48:18, 1965","journal-title":"Gastroenterology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clinchem\/32.5.840","volume":"32","author":"JM Feldman","year":"1986","unstructured":"Feldman JM: Urinary serotonin in the diagnosis of carcinoid tumor. Clin Chem 32:840?844, 1986","journal-title":"Clin Chem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(68)91528-6","volume":"2","author":"M Sandler","year":"1968","unstructured":"Sandler M, Karim SMM, William ED: Prostaglandin in amine-peptide-secreting tumors. Lancet 2:1053?1055, 1968","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00495858","volume":"52","author":"J Alumets","year":"1977","unstructured":"Alumets J, Hakanson R, Ingemannson S, Sundler F: Substance P and 5-HT in granules isolated from an intestinal argentaffin carcinoid. Histochemistry 52:217, 1977","journal-title":"Histochemistry"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI105329","volume":"45","author":"JA Oates","year":"1966","unstructured":"Oates JA, Pettinger WA, Doctor RB: Evidence for the release of bradykinin in the carcinoid syndrome. J Clin Invest 45:173?178, 1966","journal-title":"J Clin Invest"},{"key":"CR14","first-page":"255","volume":"34","author":"B Pernow","year":"1985","unstructured":"Pernow B, Waidenstrom J: Determination of 5-hydroxytryptamine, 5 hydrosyindolacetic acid and histamine in thirtythree cases of carcinoid tumor (argentaffinoma). Am J Med 34:255?260, 1985","journal-title":"Am J Med"},{"key":"CR15","first-page":"19","volume":"14","author":"E Wilander","year":"1979","unstructured":"Wilander E, Grimelius L, Portela-Gomes G, Sloan JM: Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil mid gut carcinoid tumors. Scand J Gastroenterol (suppl) 14:19?25, 1979","journal-title":"Scand J Gastroenterol (suppl)"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jso.2930270210","volume":"27","author":"WE Strodel","year":"1984","unstructured":"Strodel WE, Vinik AI, Jaffe BM, Eckhauzer F, Thompson NW: Substance P in the localization of a carcinoid tumor. J Surg Oncol 27:106?111, 1984","journal-title":"J Surg Oncol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/1097-0142(19861115)58:10<2290::AID-CNCR2820581022>3.0.CO;2-4","volume":"58","author":"KG Lucas","year":"1986","unstructured":"Lucas KG, Feldman JM: Flushing in the carcinoid syndrome and plasma kallikrein. Cancer 58:2290?2293, 1986","journal-title":"Cancer"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9343(57)90354-6","volume":"23","author":"B Pernow","year":"1957","unstructured":"Pernow B, Waldenstrom J: Determination of 5-hydroxytryptamine, 5-hydroxy indoleacetic acid and histamine in 33 cases of carcinoid (argentaffinoma). Am J Med 23:16?25, 1957","journal-title":"Am J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0026-0495(85)90009-5","volume":"34","author":"JM Feldman","year":"1985","unstructured":"Feldman JM: Increased dopamine production in patients with carcinoid tumors. Metabolism 34:255?260, 1985","journal-title":"Metabolism"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0006-291X(85)91772-3","volume":"131","author":"E Theodrosson-Norheim","year":"1985","unstructured":"Theodrosson-Norheim E, Norheism KO, Brodin E, et al: Neuropeptide K: A major tachykinin in plasma and tumor tissues from carcinoid patients. Biochem Biophys Res Commun 131:77?83, 1985","journal-title":"Biochem Biophys Res Commun"},{"key":"CR21","first-page":"293","volume-title":"Endocrine Surgery Update","author":"AI Vinik","year":"1983","unstructured":"Vinik AI, Strodel WM, Lloyd RV: Unusual gastroenteropancreatic tumors and their hormones.In Endocrine Surgery Update. NW Thompson, AI Vinik (eds). New York, Grune & Stratton, 1983, pp 293?320"},{"issue":"suppl 6b","key":"CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-9343(86)90583-8","volume":"81","author":"J Feldman","year":"1986","unstructured":"Feldman J, O'Dorisio TM: Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 81(suppl 6b):41?48, 1986","journal-title":"Am J Med"},{"issue":"suppl 6b","key":"CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(86)90584-X","volume":"81","author":"LK Kvols","year":"1986","unstructured":"Kvols LK: Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy. Am J Med 81 (suppl 6b):49?55, 1986","journal-title":"Am J Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.287.6397.932","volume":"287","author":"PN Maton","year":"1983","unstructured":"Maton PN, Camilleri M, Griffin G, Hodgson H, Allison DJ, Chadwick VS: The role of hepatic arterial embolization in the carcinoid syndrome. Br Med J 287:932?935, 1983","journal-title":"Br Med J"},{"key":"CR25","first-page":"581","volume-title":"Gut Hormones","author":"NE Gyn","year":"1981","unstructured":"Gyn NE, Kayasseh L, Keller IJ: VIP and watery diarrhea.In Gut Hormones, 2nd ed. SR Bloom, JM Polak (ed). Edinburgh, Churchill Livinston, 1981, pp 581?585","edition":"2nd ed."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1210\/jcem-48-1-50","volume":"48","author":"M Sheppard","year":"1979","unstructured":"Sheppard M, Shapiro B, Primstone B, Kronhein S, Berelowitz M, Gregory M: Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 48:50?53, 1979","journal-title":"J Clin Endocrinol Metab"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0024-3205(82)90087-X","volume":"31","author":"W Bauer","year":"1982","unstructured":"Bauer W, Briner U, Doepfner W, Waller R, Huguenin R, Marbach P, Fletcher TJ, Pless T: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133?1140, 1982","journal-title":"Life Sci"},{"key":"CR28","first-page":"824","volume":"55","author":"TP Walker","year":"1959","unstructured":"Walker TP: The determination of serotonin (5-hydroytryptamine) in human blood. J Lab Clin Med 55:824?829, 1959","journal-title":"J Lab Clin Med"},{"key":"CR29","first-page":"344","volume":"54","author":"RB Davis","year":"1959","unstructured":"Davis RB: The concentration of serotonin in normal human serum as determined by an improved method. J Lab Clin Med 54:344?351, 1959","journal-title":"J Lab Clin Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-2944(72)90016-6","volume":"6","author":"ML Das","year":"1972","unstructured":"Das ML: A rapid, sensitive method for direct estimation of serotonin in whole blood. Biochem Med 6:299?309, 1972","journal-title":"Biochem Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0021-9258(19)81408-4","volume":"216","author":"C Udenfriend","year":"1955","unstructured":"Udenfriend C, Titus E, Weissbach H: The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J Biol Chem 216:499?505, 1955","journal-title":"J Biol Chem"},{"key":"CR32","first-page":"93","volume-title":"Special Topics in Endocrinology and Metabolism, Vol 4","author":"AI Vinik","year":"1982","unstructured":"Vinik AI, Achem Karam S, Owyang C: Gastrointestinal hormones in clinical medicine.In Special Topics in Endocrinology and Metabolism, Vol 4. MP Cohen, PP Foa (eds). New York. Alan R. Liss, 1982, pp 93?138"},{"issue":"suppl 119","key":"CR33","first-page":"267","volume":"21","author":"ST Tsai","year":"1985","unstructured":"Tsai ST, Lewis E, Vinik AI: The use of a somatostatin analogue in the management of the flushing syndrome. Scand J Gastroenterol 21(suppl 119):267?274, 1985","journal-title":"Scand J Gastroenterol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM197811092991908","volume":"299","author":"J Frohlich","year":"1978","unstructured":"Frohlich J, Bloomgarden Z, Oates J, et al: The carcinoid flush provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 299:1055?1057, 1978","journal-title":"N Engl J Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","volume":"315","author":"LK Kvols","year":"1986","unstructured":"Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn R: Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 315:663?666, 1986","journal-title":"N Engl J Med"},{"issue":"suppl 119","key":"CR36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/00365528609087452","volume":"21","author":"G Richter","year":"1986","unstructured":"Richter G, Stockmann F, Lembeke B, Conlon JM, Creutzfeldt W: Short-term administration of somatostatin analogue SMS 20-1995 in patients with carcinoid tumors. Scand J Gastroenterol 21(suppl 119):193?198, 1986","journal-title":"Scand J Gastroenterol"},{"key":"CR37","first-page":"1229","volume":"313","author":"LK Kvols","year":"1985","unstructured":"Kvols LK, Martin JK, Marsh HM, Moertel CG: Carcinoid crisis: Rapid reversal of the life-threatening hypotension with a somatostatin analogue. N Engl J Med 313:1229, 1985","journal-title":"N Engl J Med"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-103-3-363","volume":"103","author":"WC Santangelo","year":"1985","unstructured":"Santangelo WC, O'Dorisio TM, Kim JG, Severino G, Krejs GJ: Pancreatic cholera syndrome?effect of a synthetic somatostatin analogue on intestinal water and ion transport. Ann Intern Med 103:363?367, 1985","journal-title":"Ann Intern Med"},{"issue":"suppl 6b","key":"CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90582-6","volume":"81","author":"A Vinik","year":"1986","unstructured":"Vinik A, Tsai S, Moattarri A, Cheung P, Eckhauser F, Cho K: Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes. Am J Med 81(suppl 6b):23?40, 1986","journal-title":"Am J Med"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0300-5089(21)00481-8","volume":"9","author":"R Arnold","year":"1980","unstructured":"Arnold R, Lankisch: Somatostatin and the gastrointestinal tract. Clin Gastroenterol 9:733?754, 1980","journal-title":"Clin Gastroenterol"},{"issue":"suppl 119","key":"CR41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/00365528609087459","volume":"21","author":"F Stockmann","year":"1986","unstructured":"Stockmann F, Richter G, Lembcke B, Conlon JM, Creutzfeldt W: Long-term treatment of patients with endocrine gastrointestinal tumors with the somatostatin analogue SMS 201-995. Scand J Gastroenterol 21 (suppl 119):230?237, 1986","journal-title":"Scand J Gastroenterol"},{"key":"CR42","first-page":"392","volume":"26","author":"G Hengl","year":"1979","unstructured":"Hengl G, Prager J, Pointner H: The influence of somatostatin on the absorption of triglycerides in partially gastrectomized subjects. Acta Hepato-Gastroenterol 26:392?395, 1979","journal-title":"Acta Hepato-Gastroenterol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gut.26.5.438","volume":"26","author":"SM Wood","year":"1985","unstructured":"Wood SM, Kraenzlin ME, Adrian TE, Bloom SR: Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue: Symptomatic and peptide responses. Gut 26:438?444, 1985","journal-title":"Gut"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/jnnp.47.12.1359","volume":"47","author":"CJM Poole","year":"1984","unstructured":"Poole CJM: Myelopathy secondary to metastatic carcinoid tumors. J Neurol Neurosurg Psychiatr 47:1359?1360, 1984","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.15.1.34","volume":"15","author":"EM Berry","year":"1974","unstructured":"Berry EM, Maunder C, Wilson M: Carcinoid myopathy and treatment with cyproheptadine (periactin). Gut 15:34?38, 1974","journal-title":"Gut"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archinte.1964.03860100076007","volume":"114","author":"D Green","year":"1964","unstructured":"Green D, Joynt RJ, Van Allen MW: Neuromyopathy associated with a malignant carcinoid tumor. Arch Intern Med 114:494?496, 1964","journal-title":"Arch Intern Med"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.48.7.719","volume":"48","author":"SJ Wroe","year":"1985","unstructured":"Wroe SJ, Ardon M, Bouden AR: Myasthenia gravis associated with a hormone producing malignant carcinoid tumor. J Neurol Neurosurg Psychiat 48:719?720, 1985","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-4800(67)90026-3","volume":"7","author":"WK O'Stern","year":"1967","unstructured":"O'Stern WK, Barnard JL Jr, Yates RD: Morphologic changes in skeletal muscle induced by serotonin treatment, a light and electron microscopy study. Exp Mol Pathol 7:145?155, 1967","journal-title":"Exp Mol Pathol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(85)80153-0","volume":"88","author":"ME Kraenzlin","year":"1985","unstructured":"Kraenzlin ME, Ching KC, Wood SM, Carr DH, Bloom SR: Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastorenterology 88:185?7, 1985","journal-title":"Gastorenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01536042\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01536042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01536042\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01536042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:07:11Z","timestamp":1625807231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01536042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":49,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1989,3]]}},"alternative-id":["BF01536042"],"URL":"https:\/\/doi.org\/10.1007\/bf01536042","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,3]]}}}